Mohammad B. Uddin

961 total citations
24 papers, 696 citations indexed

About

Mohammad B. Uddin is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Mohammad B. Uddin has authored 24 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Mohammad B. Uddin's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (4 papers). Mohammad B. Uddin is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (4 papers). Mohammad B. Uddin collaborates with scholars based in United States, Bangladesh and Japan. Mohammad B. Uddin's co-authors include Zhishan Wang, Chengfeng Yang, Yu Liu, Jean Christopher Chamcheu, Sergette Banang‐Mbeumi, Tithi Roy, Shile Huang, Ronald A. Hill, Sachin Khiste and Salman B. Hosain and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Mohammad B. Uddin

24 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad B. Uddin United States 12 449 209 93 64 43 24 696
Hoi‐Hin Kwok Hong Kong 16 418 0.9× 126 0.6× 109 1.2× 78 1.2× 29 0.7× 31 676
Bei Zhou China 16 377 0.8× 212 1.0× 50 0.5× 85 1.3× 21 0.5× 30 608
Yohan Han South Korea 16 563 1.3× 217 1.0× 49 0.5× 79 1.2× 46 1.1× 33 836
Aoxue Wang China 12 384 0.9× 253 1.2× 83 0.9× 121 1.9× 76 1.8× 32 866
Jiege Huo China 19 403 0.9× 147 0.7× 229 2.5× 79 1.2× 31 0.7× 56 836
Jungwhoi Lee South Korea 17 358 0.8× 146 0.7× 183 2.0× 71 1.1× 16 0.4× 37 742
Ping Pei United States 16 359 0.8× 133 0.6× 115 1.2× 49 0.8× 13 0.3× 32 783
Mohamed E. Abdraboh Egypt 12 281 0.6× 85 0.4× 140 1.5× 43 0.7× 17 0.4× 23 571
Moo Rim Kang South Korea 15 476 1.1× 243 1.2× 71 0.8× 44 0.7× 15 0.3× 26 754
Kenji Hyoudou Japan 14 262 0.6× 112 0.5× 88 0.9× 81 1.3× 14 0.3× 15 491

Countries citing papers authored by Mohammad B. Uddin

Since Specialization
Citations

This map shows the geographic impact of Mohammad B. Uddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad B. Uddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad B. Uddin more than expected).

Fields of papers citing papers by Mohammad B. Uddin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad B. Uddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad B. Uddin. The network helps show where Mohammad B. Uddin may publish in the future.

Co-authorship network of co-authors of Mohammad B. Uddin

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad B. Uddin. A scholar is included among the top collaborators of Mohammad B. Uddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad B. Uddin. Mohammad B. Uddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uddin, Mohammad B., Zhishan Wang, & Chengfeng Yang. (2024). Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities. Advanced Science. 12(4). e2403936–e2403936. 2 indexed citations
2.
3.
4.
Fan, Teresa W.‐M., Saeed Daneshmandi, Teresa Cassel, et al.. (2022). Polarization and β-Glucan Reprogram Immunomodulatory Metabolism in Human Macrophages and Ex Vivo in Human Lung Cancer Tissues. The Journal of Immunology. 209(9). 1674–1690. 11 indexed citations
5.
Uddin, Mohammad B., Ronald A. Hill, Xin Gu, et al.. (2022). p53 missense mutant G242A subverts natural killer cells in sheltering mouse breast cancer cells against immune rejection. Experimental Cell Research. 417(1). 113210–113210. 11 indexed citations
6.
Wang, Zhishan, Mohammad B. Uddin, Jie Xie, et al.. (2022). Chronic Hexavalent Chromium Exposure Upregulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-Like Property, and Tumorigenesis. Toxicological Sciences. 187(1). 51–61. 25 indexed citations
7.
Uddin, Mohammad B., Zhishan Wang, & Chengfeng Yang. (2021). The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis. Molecular Cancer. 20(1). 61–61. 104 indexed citations
8.
Xie, Jie, Yongsheng Fan, Jianmei Su, et al.. (2020). Low dose lead exposure at the onset of puberty disrupts spermatogenesis-related gene expression and causes abnormal spermatogenesis in mouse. Toxicology and Applied Pharmacology. 393. 114942–114942. 14 indexed citations
9.
Uddin, Mohammad B., Zhishan Wang, & Chengfeng Yang. (2020). Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics. Theranostics. 10(7). 3164–3189. 46 indexed citations
10.
Khiste, Sachin, Zhijun Liu, Mohammad B. Uddin, et al.. (2019). Ceramide–Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations. Molecular Cancer Therapeutics. 19(2). 564–574. 19 indexed citations
11.
Chamcheu, Jean Christopher, Tithi Roy, Mohammad B. Uddin, et al.. (2019). Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy. Cells. 8(8). 803–803. 142 indexed citations
12.
Uddin, Mohammad B., Salman B. Hosain, Sachin Khiste, et al.. (2018). An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells. Biochemical Pharmacology. 160. 134–145. 83 indexed citations
13.
Chamcheu, Jean Christopher, Islam Rady, Abu Bakar Siddique, et al.. (2018). Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling. International Journal of Molecular Sciences. 19(6). 1791–1791. 29 indexed citations
14.
Khiste, Sachin, Salman B. Hosain, Yixuan Dong, et al.. (2017). Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo. Scientific Reports. 7(1). 2976–2976. 8 indexed citations
15.
16.
Nasrullah, Mohammad, et al.. (2017). Acetylcholinesterase and Butyrylcholinesterase Enzyme Inhibitory Effect of Alangium salviifolium (L. f.) Wang pericarp Extracts with Their Phytochemical and Antioxidant Values. Journal of Pharmaceutical Research International. 19(5). 1–11. 2 indexed citations
17.
Hosain, Salman B., Sachin Khiste, Mohammad B. Uddin, et al.. (2016). Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells. Oncotarget. 7(37). 60575–60592. 40 indexed citations
18.
Jahan, Ismet Ara, et al.. (2013). A Comparative Study on Antioxidant Properties of Two Phyllanthus Species Growing in Bangladesh. Dhaka University Journal of Pharmaceutical Sciences. 11(2). 191–197. 9 indexed citations
19.
Hamid, Kaiser, et al.. (2012). In vitro studies on antibacterial, antifungal, and cytotoxic properties of Leucas aspera. 2012(4). 183–187. 6 indexed citations
20.
Nabi, A.H.M. Nurun, Mohammad B. Uddin, Tsutomu Nakagawa, et al.. (2005). Roles of His9 (P2 subsite) and His13 (P3' subsite) in angiotensinogen for catalytic reaction of renin. International Journal of Molecular Medicine. 16(1). 103–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hoi‐Hin Kwok Breakdown of academic impact, for papers by Bei Zhou Breakdown of academic impact, for papers by Yohan Han Breakdown of academic impact, for papers by Aoxue Wang Breakdown of academic impact, for papers by Jiege Huo Breakdown of academic impact, for papers by Jungwhoi Lee Breakdown of academic impact, for papers by Ping Pei Breakdown of academic impact, for papers by Mohamed E. Abdraboh Breakdown of academic impact, for papers by Moo Rim Kang Breakdown of academic impact, for papers by Kenji Hyoudou
Rankless by CCL
2026